Five-year survival in patients with extensive-stage small cell lung cancer treated with atezolizumab in the Phase III IMpower133 study and the Phase III IMbrella A extension study

Martin Reck, Stephen V. Liu, Jong Seok Lee et al.|Lung Cancer|2024

Cited by 66